All regulatory updates
894 results found
ECHA opens public consultation on draft 13th recommendation for inclusion of SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for prioritising certain Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation period runs from 2 February 2026 to 2 May 2026. This is a key SVHC-to-authorisation pipeline milestone: affected manufacturers/importers/downstream users should review whether any of the recommended substances are in their supply chains and consider submitting comments, as future Annex XIV inclusion can lead to authorisation obligations and phase-out pressures.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for inclusion of certain Candidate List SVHCs in REACH Annex XIV (Authorisation List). This is a key SVHC-related downstream step: substances recommended for Annex XIV can later be added by the European Commission via amendment, triggering authorisation requirements (including latest application and sunset dates) for continued use. Consultation window shown is 02 Feb 2026 to 02 May 2026, with linked draft recommendation and supporting documents.
ECHA opened public consultation on the Draft 13th Recommendation to include four SVHCs in the REACH Authorisation List (Annex XIV)
ECHA published the Draft 13th Recommendation and opened a public consultation (2 Feb 2026 to 2 May 2026) on prioritising four SVHCs for potential inclusion in the REACH Authorisation List (Annex XIV): bumetrizole (UV-326), UV-329, triphenyl phosphate, and 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one. This consultation is a key step in the SVHC-to-authorisation pathway; affected companies should assess uses and consider submitting evidence on uses, alternatives, and socio-economic impacts.
ECHA opens consultation on draft recommendation to include four Candidate List substances in the REACH Authorisation List (Annex XIV)
ECHA launched a public consultation on its draft recommendation to the European Commission to add four Candidate List substances to the REACH Authorisation List (Annex XIV). Compliance teams should monitor this pipeline step because Annex XIV inclusion can introduce authorisation obligations for continued use/placing on the market (subject to future sunset dates set in any eventual Annex XIV entries). The consultation is open for stakeholder input until 2 May 2026.
ECHA opens public consultation on draft 13th recommendation for inclusion of SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for prioritising certain Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation period runs from 2 February 2026 to 2 May 2026. This is a key SVHC-to-authorisation pipeline milestone: affected manufacturers/importers/downstream users should review whether any of the recommended substances are in their supply chains and consider submitting comments, as future Annex XIV inclusion can lead to authorisation obligations and phase-out pressures.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for inclusion of certain Candidate List SVHCs in REACH Annex XIV (Authorisation List). This is a key SVHC-related downstream step: substances recommended for Annex XIV can later be added by the European Commission via amendment, triggering authorisation requirements (including latest application and sunset dates) for continued use. Consultation window shown is 02 Feb 2026 to 02 May 2026, with linked draft recommendation and supporting documents.
ECHA opens public consultation on the draft 13th recommendation for inclusion of Candidate List SVHCs in REACH Annex XIV (Authorisation List) (02 Feb 2026–02 May 2026)
ECHA has opened a public consultation on its draft 13th recommendation of priority SVHCs from the Candidate List for possible inclusion in REACH Annex XIV (Authorisation List). The consultation window shown is 02 February 2026 through 02 May 2026. This is a key step in the SVHC-to-authorisation pipeline; if substances are later added to Annex XIV by the European Commission, authorisation requirements could apply for non-exempt uses after future latest application/sunset dates. Compliance teams should evaluate business impacts, substitution plans, and consider submitting comments/evidence during the consultation period.
ECHA opens public consultation on the draft 13th recommendation for inclusion of Candidate List SVHCs in REACH Annex XIV (Authorisation List) (02 Feb 2026–02 May 2026)
ECHA has opened a public consultation on its draft 13th recommendation of priority SVHCs from the Candidate List for possible inclusion in REACH Annex XIV (Authorisation List). The consultation window shown is 02 February 2026 through 02 May 2026. This is a key step in the SVHC-to-authorisation pipeline; if substances are later added to Annex XIV by the European Commission, authorisation requirements could apply for non-exempt uses after future latest application/sunset dates. Compliance teams should evaluate business impacts, substitution plans, and consider submitting comments/evidence during the consultation period.
ECHA launched public consultation for the 13th draft recommendation to include SVHCs in Annex XIV (Authorisation List)
ECHA opened a public consultation on its 13th draft recommendation for prioritising SVHCs for inclusion in REACH Annex XIV (Authorisation List). The recommendation status is shown as 'included in draft recommendation' with a consultation window from 02-Feb-2026 to 02-May-2026. While this is not yet a binding Annex XIV amendment, it is a key step toward future authorisation requirements (e.g., eventual latest application and sunset dates) for substances selected by the European Commission. Compliance teams should review whether any listed substances are used in their products/processes and consider submitting comments during the consultation period and preparing for potential downstream authorisation impacts if the Commission proceeds.
ECHA launched public consultation for the 13th draft recommendation to include SVHCs in Annex XIV (Authorisation List)
ECHA opened a public consultation on its 13th draft recommendation for prioritising SVHCs for inclusion in REACH Annex XIV (Authorisation List). The recommendation status is shown as 'included in draft recommendation' with a consultation window from 02-Feb-2026 to 02-May-2026. While this is not yet a binding Annex XIV amendment, it is a key step toward future authorisation requirements (e.g., eventual latest application and sunset dates) for substances selected by the European Commission. Compliance teams should review whether any listed substances are used in their products/processes and consider submitting comments during the consultation period and preparing for potential downstream authorisation impacts if the Commission proceeds.
ECHA opened public consultation on the Draft 13th Recommendation to include four SVHCs in the REACH Authorisation List (Annex XIV)
ECHA published the Draft 13th Recommendation and opened a public consultation (2 Feb 2026 to 2 May 2026) on prioritising four SVHCs for potential inclusion in the REACH Authorisation List (Annex XIV): bumetrizole (UV-326), UV-329, triphenyl phosphate, and 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one. This consultation is a key step in the SVHC-to-authorisation pathway; affected companies should assess uses and consider submitting evidence on uses, alternatives, and socio-economic impacts.
ECHA publishes Draft 13th Recommendation documents for potential inclusion of priority SVHCs in REACH Annex XIV (Authorisation List)
ECHA published supporting documents for its Draft 13th Recommendation of priority substances for potential inclusion in REACH Annex XIV (Authorisation List), including draft Annex XIV entry structures and background/prioritisation documents. This is a draft/pipeline step (not yet a binding Annex XIV amendment), but it signals which SVHCs may be advanced toward authorisation requirements, informing early substitution planning and monitoring of latest application date/sunset date proposals once finalized by the European Commission.
ECHA opened consultation on the 13th draft recommendation to include SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its 13th draft recommendation for prioritising Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation runs from 2 February 2026 to 2 May 2026. If finalised and later adopted by the European Commission, Annex XIV inclusion would introduce authorisation obligations (including latest application and sunset dates). Compliance teams should review the draft recommendation and background documents, assess portfolio impacts for listed SVHCs, and consider submitting comments.
ECHA opens public consultation on draft recommendation to include four Candidate List substances in REACH Authorisation List (Annex XIV)
ECHA opened a public consultation on its draft recommendation to the European Commission to include four SVHC Candidate List substances in REACH Annex XIV (Authorisation List). Stakeholders are invited to submit information (e.g., uses, volumes, potential exemptions, and supply chain impacts) to inform ECHA’s final recommendation. This is a proposed/pipeline step (not yet a legal Annex XIV amendment) but is highly relevant for companies using these substances, as Annex XIV listing can lead to authorisation obligations and potential phase-out/substitution planning.
ECHA opened consultation on the 13th draft recommendation to include SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its 13th draft recommendation for prioritising Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation runs from 2 February 2026 to 2 May 2026. If finalised and later adopted by the European Commission, Annex XIV inclusion would introduce authorisation obligations (including latest application and sunset dates). Compliance teams should review the draft recommendation and background documents, assess portfolio impacts for listed SVHCs, and consider submitting comments.
European Commission publishes updated RoHS exemptions tracker (“Exemptions list: validity and rolling plan” – Feb 2026)
The European Commission published an updated consolidated RoHS exemptions tracking file (“Exemptions list: validity and rolling plan” – February 2026). This tracker is used to monitor Annex III/IV exemption validity/expiry dates and the Commission’s rolling plan for evaluation and decisions, supporting compliance planning for upcoming exemption expirations and renewal timelines. It is not itself a delegated directive amending Annex III/IV, but it is an official planning/monitoring update that compliance teams use to track anticipated exemption changes.
USGBC releases LEED v5 Reference Guide for Operations and Maintenance (February 2026 Edition) reflecting February 2026 addenda
USGBC released the LEED v5 Reference Guide for Operations and Maintenance, February 2026 Edition, and indicates it reflects LEED addenda released in February 2026. Teams preparing LEED v5 O+M certification/recertification documentation should ensure they are using this updated reference guide edition to align interpretations, documentation guidance, and examples with the most recent addenda cycle.
ECHA announces spring 2026 60-day consultation on SEAC draft opinion for EU-wide PFAS restriction
ECHA published a notice announcing the next step in the EU-wide PFAS restriction process under REACH: a planned 60-day consultation on SEAC’s draft opinion (socio-economic impacts and alternatives). The consultation is expected to start after SEAC’s March 2026 meeting, run for 60 days, and be conducted via a structured survey (no attachments). This is a key stakeholder engagement milestone for companies and downstream users to prepare socio-economic and alternatives information for the restriction evaluation.
EPA posts updated statistics for TSCA New Chemicals Program case inventory (as of Feb. 1, 2026)
EPA updated its TSCA New Chemicals Program statistics page with current counts of PMNs, SNUNs, and MCANs under review (as of Feb. 1, 2026). While not a rule change, the updated workload/case-status metrics can affect company expectations for review timing and resourcing for Section 5 submissions, including tracking potential delays in risk assessment and determination steps.
USACE Engineering and Construction Bulletin (ECB) 2026-3 revokes LEED requirement for applicable Army projects and shifts to CEQ Guiding Principles checklists
USACE issued Engineering and Construction Bulletin (ECB) 2026-3 directing that applicable Army military projects discontinue use of the LEED rating system (previously requiring LEED Silver under referenced criteria) and instead use Council on Environmental Quality (CEQ) 2020 Guiding Principles for Sustainable Federal Buildings checklists. The bulletin states the change is effective immediately, with limited grandfathering for projects already registered for LEED and with construction contracts awarded including third-party certification costs prior to a specified date. This impacts LEED-related compliance planning for Army projects, including contract language, sustainability documentation workflows, and third-party certification budgeting.